About
Portfolio
Team
News
Contact
中文
About
Portfolio
Team
News
Contact
中文
Home
News
News
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies
2022-8-05
Novaremed enters into an exclusive option and license agreement with NeuroFront for the non-opioid neuropathic pain treatment, NRD.E1, for Greater China and Singapore
2022-7-21
Plexium Announces $102m Financing to Advance Pipeline of Targeted Protein Degradation Therapies and Technology Platform
2022-2-23
OncXerna is selected as Global Top 5 Precision Medicine Startups
2022-2-17
Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients
2022-1-10
Pivotal bioVenture Partners China Announces Formation of SanReno Therapeutics
2021-12-03
Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market
2021-11-29
Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
2021-11-23
Arctic Vision’s Collaboration Partner, Clearside Biomedical Inc., Has Obtained U.S. FDA Approval of XIPERE™ (ARVN001) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
2021-10-26
Arctic Vision Obtains China IND Clearance for Phase III Study of ARVN003, the First in China for Presbyopia Treatment
2021-9-03
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India
2021-8-15
QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements
2021-8-09
Engrail Therapeutics Extends Series A Financing to $64 Million
2021-8-03
Arctic Vision Received China IND Clearance for Phase III Study of ARVN002 to Reduce Paediatric Myopia Progression
2021-8-02
NeuroFront Announces Exclusive Licensing Agreement for Development and Commercialization of Neurolief’s Relivion® in Greater China and South Korea
2021-7-09
Exscientia announces investment of up to $525M
2021-4-26
Evommune完成1250万美元种子轮融资
2020-11-20
Oncologie(鼎航医药)公布最新临床研究数据
2020-9-21
Arctic Vision Announces US$32MN in Series A
2020-7-14
Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China
2018-6-07
Pivotal bioVenture Partners China Closes Inaugural $150 Million Early Stage VC Fund
2018-5-24